We Need a Better Way Of Distributing the COVID-19 Vaccine. Here’s How To Do It. January 12, 2021 Perspective In an op-ed for The Washington Post, KFF President Drew Altman calls for a simplification of the troubled COVID-19 vaccine distribution system.
The Challenge Of Vaccine Hesitancy In Rural America January 12, 2021 Perspective In his latest Axios column, Drew Altman looks at the challenge of vaccine hesitancy in rural America and its implications. One of them: a highly tailored outreach campaign is needed. “Addressing this hesitancy will require convincing rural Americans about the seriousness of the pandemic, and then that the vaccine is a way to protect them, their families and their way of life,” he said.
Real Progress Is Possible On Vaccine Hesitancy December 15, 2020 Perspective Drew Altman’s Axios column draws on data from the new KFF COVID-19 Vaccine Monitor to assess where the country stands on vaccine hesitancy.
COVID-19 Is Causing Health Spending To Go Down December 2, 2020 Perspective New analysis from Drew Altman in his latest Axios column on the impact of the coronavirus pandemic on national health spending.
The Exit Polls Show The Need To Confront COVID-19 Denial in Red America November 17, 2020 Perspective Drew Altman analyzes the exit polls in his latest Axios column. While Biden voters see COVID-19 as a top priority, Trump supporters are still largely pandemic deniers, echoing the President.
Mixed Prospects for Vaccinating Children October 29, 2021 Perspective In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.
Joe Biden’s Big Lead on Health Care Issues October 21, 2020 Perspective In an Axios column, Drew Altman discusses how this election year health isn’t a single issue — but several — and Joe Biden has the edge over President Trump on all of them, even as opposition to the ACA remains popular with Trump’s base.
Joe Biden’s New Health Care Agenda (and CMS’s Big Role In It) January 11, 2021 Perspective With the Georgia runoff elections giving Democrats control of the U.S. Senate, Drew Altman discusses President-elect Biden’s potential health care agenda and suggests that the Centers for Medicare & Medicaid Services could have an expanded role and that it may be time to rename it and elevate it to a cabinet agency.
The Coronavirus Economy Could Make a Medicare Buy-in More Popular May 18, 2020 Perspective In this Axios column, Drew Altman analyzes recent unemployment numbers for older workers and discusses how millions of uninsured older workers could lead to a greater push for incremental Medicare expansion proposals.
Why Drug Price Negotiation Has Staying Power June 25, 2021 Perspective In this Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating drug prices.
